Usefulness of echocardiographic left ventricular hypertrophy and silent ischemia in predicting new cardiac events in elderly patients with systemic hypertension or coronary artery disease

W. S. Aronow, S. Epstein, Mordecai Koenigsberg

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The authors performed a prospective study to correlate echocardiographic left ventricular hypertrophy (LVH) and silent ischemia (SI) detected by twenty-four-hour ambulatory electrocardiographic monitoring with new cardiac events in 355 patients, mean age eighty-two ± eight years, with systemic hypertension or coronary artery disease (CAD). Cardiac events included myocardial infarction, primary ventricular fibrillation, or sudden cardiac death. Mean follow-up was thirty-one ± seven months (range twelve to forty). Cardiac events occurred in 28 of 147 patients (19%) without LVH or SI (A), in 56 of 113 patients (50%) with LVH and no SI (B), in 16 of 29 patients (55%) with SI and no LVH (C), and in 52 of 66 patients (79%) with LVH and SI (D). Significant p values were p < 0.001 comparing D with A, D with B, C with A, and B with A; and p < 0.02 comparing D with C. These data indicate that echocardiographic LVH and SI detected by ambulatory electrocardiographic monitoring are independent risk factors for new cardiac events in elderly patients with systemic hypertension or CAD.

Original languageEnglish (US)
Pages (from-to)189-193
Number of pages5
JournalAngiology
Volume41
Issue number3
StatePublished - 1990
Externally publishedYes

Fingerprint

Left Ventricular Hypertrophy
Coronary Artery Disease
Ischemia
Hypertension
Ambulatory Electrocardiography
Sudden Cardiac Death
Ventricular Fibrillation
Myocardial Infarction
Prospective Studies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{479bf28bf4294b00ae298c56092ada49,
title = "Usefulness of echocardiographic left ventricular hypertrophy and silent ischemia in predicting new cardiac events in elderly patients with systemic hypertension or coronary artery disease",
abstract = "The authors performed a prospective study to correlate echocardiographic left ventricular hypertrophy (LVH) and silent ischemia (SI) detected by twenty-four-hour ambulatory electrocardiographic monitoring with new cardiac events in 355 patients, mean age eighty-two ± eight years, with systemic hypertension or coronary artery disease (CAD). Cardiac events included myocardial infarction, primary ventricular fibrillation, or sudden cardiac death. Mean follow-up was thirty-one ± seven months (range twelve to forty). Cardiac events occurred in 28 of 147 patients (19{\%}) without LVH or SI (A), in 56 of 113 patients (50{\%}) with LVH and no SI (B), in 16 of 29 patients (55{\%}) with SI and no LVH (C), and in 52 of 66 patients (79{\%}) with LVH and SI (D). Significant p values were p < 0.001 comparing D with A, D with B, C with A, and B with A; and p < 0.02 comparing D with C. These data indicate that echocardiographic LVH and SI detected by ambulatory electrocardiographic monitoring are independent risk factors for new cardiac events in elderly patients with systemic hypertension or CAD.",
author = "Aronow, {W. S.} and S. Epstein and Mordecai Koenigsberg",
year = "1990",
language = "English (US)",
volume = "41",
pages = "189--193",
journal = "Angiology",
issn = "0003-3197",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Usefulness of echocardiographic left ventricular hypertrophy and silent ischemia in predicting new cardiac events in elderly patients with systemic hypertension or coronary artery disease

AU - Aronow, W. S.

AU - Epstein, S.

AU - Koenigsberg, Mordecai

PY - 1990

Y1 - 1990

N2 - The authors performed a prospective study to correlate echocardiographic left ventricular hypertrophy (LVH) and silent ischemia (SI) detected by twenty-four-hour ambulatory electrocardiographic monitoring with new cardiac events in 355 patients, mean age eighty-two ± eight years, with systemic hypertension or coronary artery disease (CAD). Cardiac events included myocardial infarction, primary ventricular fibrillation, or sudden cardiac death. Mean follow-up was thirty-one ± seven months (range twelve to forty). Cardiac events occurred in 28 of 147 patients (19%) without LVH or SI (A), in 56 of 113 patients (50%) with LVH and no SI (B), in 16 of 29 patients (55%) with SI and no LVH (C), and in 52 of 66 patients (79%) with LVH and SI (D). Significant p values were p < 0.001 comparing D with A, D with B, C with A, and B with A; and p < 0.02 comparing D with C. These data indicate that echocardiographic LVH and SI detected by ambulatory electrocardiographic monitoring are independent risk factors for new cardiac events in elderly patients with systemic hypertension or CAD.

AB - The authors performed a prospective study to correlate echocardiographic left ventricular hypertrophy (LVH) and silent ischemia (SI) detected by twenty-four-hour ambulatory electrocardiographic monitoring with new cardiac events in 355 patients, mean age eighty-two ± eight years, with systemic hypertension or coronary artery disease (CAD). Cardiac events included myocardial infarction, primary ventricular fibrillation, or sudden cardiac death. Mean follow-up was thirty-one ± seven months (range twelve to forty). Cardiac events occurred in 28 of 147 patients (19%) without LVH or SI (A), in 56 of 113 patients (50%) with LVH and no SI (B), in 16 of 29 patients (55%) with SI and no LVH (C), and in 52 of 66 patients (79%) with LVH and SI (D). Significant p values were p < 0.001 comparing D with A, D with B, C with A, and B with A; and p < 0.02 comparing D with C. These data indicate that echocardiographic LVH and SI detected by ambulatory electrocardiographic monitoring are independent risk factors for new cardiac events in elderly patients with systemic hypertension or CAD.

UR - http://www.scopus.com/inward/record.url?scp=0025219474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025219474&partnerID=8YFLogxK

M3 - Article

C2 - 2137998

AN - SCOPUS:0025219474

VL - 41

SP - 189

EP - 193

JO - Angiology

JF - Angiology

SN - 0003-3197

IS - 3

ER -